iSpecimen Inc. Common Stock
ISPCStock
$2.21−94.47%52W
Market Cap$3.39M
P/E—
Div yield—
Beta1.65
Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-89.40%
Price vs S&P 500 (4W)-15.15%
VGM Score24.92
Market Capitalization$3.39M
Analyst Recommendations
Sep 2024
Oct 2024
Nov 2024
Dec 2024
4.14
4.14
4.14
4.14
Industry Peers — R&D — Physical Sciences(15)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
ISPCiSpecimen Inc. Common Stock | C | F | D | $2.21 |
| IQVIQVIA Holdings Inc. | C | C | B | $210.49 |
| INCYIncyte Genomics Inc | C | A | B | $116.65 |
| MEDPMedpace Holdings, Inc. Common Stock | F | B | B | $537.92 |
| ICLRIcon Plc | C | C | B | $170.00 |
| CRLCharles River Laboratories International, Inc. | D | D | B | $229.16 |
| ABSIAbsci Corporation Common Stock | F | F | A | $8.23 |
| NRCNRC Health Common Stock | D | D | B | $21.94 |
| OABIOmniAb, Inc. Common Stock | D | C | B | $2.04 |
| MXCTMaxCyte, Inc. Common Stock | C | D | B | $1.35 |
| ONMDOneMedNet Corp Class A Common Stock | D | C | C | $0.69 |
About
iSpecimen Inc is a technology-enabled biospecimen supplier that connects life science researchers and pharmaceutical companies with human tissues, fluids, and stem cells. The company procures specimens from hospitals, laboratories, and medical facilities globally, with operations primarily concentrated in the Americas. iSpecimen enables drug development and clinical research by providing researchers access to the biosamples necessary for their studies.